期刊： JOURNAL OF INTERNAL MEDICINE, 2022; 291 (5)
Objectives Liver-derived apolipoprotein B-100 (ApoB100) is an autoantigen that is recognized by atherogenic CD4(+) T cells in cardiovascular disease (......
期刊： JOURNAL OF INTERNAL MEDICINE, 2022; 291 (2)
Background and objectives The absence of obstructive coronary artery disease (CAD) in patients with angina is common, but its prognosis is debated. We......
期刊： JOURNAL OF INTERNAL MEDICINE, 2022; 292 (6)
Background Dyspnea is common after COVID-19. Though the underlying mechanisms are largely unknown, lung perfusion abnormalities could contribute to li......
期刊： JOURNAL OF INTERNAL MEDICINE, 2022; 292 (1)
Lung cancer causes more deaths than breast, cervical, and colorectal cancer combined. Nevertheless, population-based lung cancer screening is still no......
期刊： JOURNAL OF INTERNAL MEDICINE, 2022; 292 (3)
DNA methylation is an epigenetic modification that has consistently been shown to be linked with a variety of human traits and diseases. Because DNA m......
期刊： JOURNAL OF INTERNAL MEDICINE, 2022; 292 (1)
The blood-brain barrier (BBB) is essential for creating and maintaining tissue homeostasis in the central nervous system (CNS), which is key for prope......
期刊： JOURNAL OF INTERNAL MEDICINE, 2022; 291 (3)
Background Recent studies demonstrate that prothrombotic antiphospholipid antibodies (aPL) are overrepresented in patients with myocardial infarction ......
期刊： JOURNAL OF INTERNAL MEDICINE, 2022; 291 (5)
Background The cardiovascular benefit from n-3 polyunsaturated fatty acids (PUFAs) after acute myocardial infarction (AMI) is controversial, and the i......
